Cita APA (7a ed.)
Yue, J., Zhang, J., Wang, S., Zhang, L., Zeng, X., Li, H., . . . Hui, Z. (2026). Paclitaxel liposome with anti–HER-2 drugs as first-line therapy for recurrent/metastatic HER-2–positive breast cancer: A real-world study. Holistic Integrative Oncology, 5(1), 1-12.
Cita Chicago Style (17a ed.)
Yue, Jian, Jin Zhang, Shusen Wang, Lili Zhang, Xiaohua Zeng, Huiping Li, Fei Ma, y Zhouguang Hui. "Paclitaxel Liposome with Anti–HER-2 Drugs as First-line Therapy for Recurrent/metastatic HER-2–positive Breast Cancer: A Real-world Study." Holistic Integrative Oncology 5, no. 1 (2026): 1-12.
Cita MLA (9a ed.)
Yue, Jian, et al. "Paclitaxel Liposome with Anti–HER-2 Drugs as First-line Therapy for Recurrent/metastatic HER-2–positive Breast Cancer: A Real-world Study." Holistic Integrative Oncology, vol. 5, no. 1, 2026, pp. 1-12.
Precaución: Estas citas no son 100% exactas.